Do we really need the robot? Laparoscopic vs. robotic-assisted cholecystectomyThe minimally invasive laparoscopic approach already has a great safety rep. Updated Canadian guidelines for management of chronic hepatitis B2025 CASL/AMMI Canada guidelines present recommendations for universal adult HBV screening, vaccination, laboratory assessment and treatment. OTC survey 2025: Top recommended brands for gastric issues Between October 2024 and January 2025, more than 1,800 pharmacists and 800 physicians were asked about which brands they personally recommend. NEW PRODUCT: Iqirvo Get the info you need on this new product, part of our drug news roundup for July. NEW PRODUCT: Rebyota for C. difficile prevention Get the info you need on this new product, part of our drug news roundup for July. Can fecal microbiota therapy be used as a first-line treatment for C. difficile? Study examines the use of fecal microbiota transplantation versus oral vancomycin for primary treatment of Clostridioides difficile infection. A spoonful of probiotics to keep the fever at bay? Probiotics may shorten fever time in children with respiratory tract infection. Semaglutide to undergo Health Canada priority review for treatment of MASH Novo Nordisk announces Health Canada has granted priority review status for once-weekly semaglutide to treat metabolic dysfunction-associated steatohepatitis. NEW DRUG: Vyloy Get the info you need on this new drug, part of our drug news roundup for April. NEW DRUG: Fruzaqla for metastatic colon cancer Get the info you need on this new drug, part of our drug news roundup for April. First Previous 2 3 4 5 6 Next Last
